PubRank

Juliette Hukin

Author PubWeight™ 24.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer 2008 2.50
2 Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 2012 1.88
3 De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatr Blood Cancer 2014 1.39
4 Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 2005 1.24
5 A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. Eur J Cancer 2009 1.24
6 Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 2007 1.21
7 Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. Cancer Res 2013 1.10
8 Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 2002 1.04
9 Cerebello-thalamo-cerebral connections in pediatric brain tumor patients: impact on working memory. Neuroimage 2011 1.02
10 Clinical and neuroanatomical predictors of cerebellar mutism syndrome. Neuro Oncol 2012 0.99
11 Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study. Cancer 2005 0.96
12 Intracystic treatments for craniopharyngioma. Neurosurg Focus 2010 0.90
13 A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer 2010 0.89
14 Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. Cancer 2008 0.89
15 Novel Mutations in FA2H-Associated Neurodegeneration: An Underrecognized Condition? J Child Neurol 2012 0.88
16 Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study. J Neurooncol 2014 0.88
17 EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study. Cancer 2015 0.85
18 The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience. Childs Nerv Syst 2014 0.84
19 Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review. Clin Neuropathol 2014 0.82
20 Late mortality in pediatric patients with craniopharyngioma. J Neurooncol 2010 0.81
21 Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006. Brain Pathol 2012 0.79
22 Malaysian siblings with friedreich ataxia and chorea: a novel deletion in the frataxin gene. Can J Neurol Sci 2004 0.78
23 Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. Radiother Oncol 2006 0.77
24 Optic pathway gliomas in adolescence--time to challenge treatment choices? Neuro Oncol 2013 0.77
25 Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation—a report of two cases. Childs Nerv Syst 2014 0.76
26 Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols. Pediatr Blood Cancer 2014 0.75
27 Intracranial tumors in infants: long-term functional outcome, survival, and its predictors. Childs Nerv Syst 2012 0.75
28 Occurrence of basal ganglia germ cell tumors without a mass. Arch Neurol 2009 0.75